Citation Impact
Citing Papers
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Hypersensitivity from Intravenous Iron Products
2014
Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy
2015
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis
2008 Standout
When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found
2013
Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients
2009
Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths
2011 Standout
Induced pluripotent stem cells — opportunities for disease modelling and drug discovery
2011
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
2014 Standout
A comprehensive map of molecular drug targets
2016 Standout
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)
2013
Oral Anticoagulant Therapy
2012 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Fibrate/Statin Initiation in Warfarin Users and Gastrointestinal Bleeding Risk
2010
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment
2009
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
2005 Standout
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Pharmacogenomics of 4-Hydroxycoumarin Anticoagulants
2008
The REDCap consortium: Building an international community of software platform partners
2019 Standout
WITHDRAWN—a resource for withdrawn and discontinued drugs
2015
Determinants of Under-Reporting of Adverse Drug Reactions
2009
The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement
2015 Standout
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome
2014
Changes in causes of death in systemic sclerosis, 1972–2002
2007 Standout
Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate
2009
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists
2011
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines
2013
Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management
2014
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
2010 Standout
Hospitalization costs associated with warfarin‐related bleeding events among older community‐dwelling adults
2010
Surveillance of Prescription Drug-Related Mortality Using Death Certificate Data
2007
Active Computerized Pharmacovigilance Using Natural Language Processing, Statistics, and Electronic Health Records: A Feasibility Study
2009
An Educational Intervention to Improve Physician Reporting of Adverse Drug Reactions
2006
Using population-based routine data for evidence-based health policy decisions: lessons from three examples of setting and evaluating national health policy in Australia, the UK and the USA
2007
Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension
2009 StandoutNobel
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation
2012
Emerging causes of iron deficiency anemia refractory to oral iron supplementation
2013
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention
2009
The ChEMBL database in 2017
2016 Standout
Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care
2011
Cardiac Safety in Clinical Trials of Phosphodiesterase 5 Inhibitors
2005
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
Structural and functional insights into human vitamin K epoxide reductase and vitamin K epoxide reductase-like1
2013
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
2013 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
The increase in pulmonary arterial pressure caused by hypoxia depends on iron status
2008 StandoutNobel
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
2017 Standout
Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality
2014
Drug‐Induced QT‐Interval Prolongation: Considerations for Clinicians
2010
National Estimates of Emergency Department Visits for Hemorrhage-Related Adverse Events From Clopidogrel Plus Aspirin and From Warfarin
2010
Oral Apixaban for the Treatment of Acute Venous Thromboembolism
2013 Standout
Mining electronic health records: towards better research applications and clinical care
2012 Standout
DLS and zeta potential – What they are and what they are not?
2016 Standout
Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate
2011
Age-Related Pharmacokinetic and Pharmacodynamic Changes and Related Risk of Adverse Drug Reactions
2010
The First Evaluation of a Novel Vitamin K Antagonist, Tecarfarin (ATI-5923), in Patients With Atrial Fibrillation
2009
Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum
2008
Rapid and Deep Profiling of Human Induced Pluripotent Stem Cell Proteome by One-shot NanoLC–MS/MS Analysis with Meter-scale Monolithic Silica Columns
2012 StandoutNobel
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Market withdrawal of new molecular entities approved in the United States from 1980 to 2009
2011
Tailored interventions to address determinants of practice
2015 Standout
Pulmonary Arterial Hypertension
2006
Clinical Research Informatics: Survey of Recent Advances and Trends in a Maturing Field
2013
Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
2002
Guidelines for the Primary Prevention of Stroke
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Management of Atrial Fibrillation and Venous Thromboembolism
2012
Article Commentary: Penny-Wise, Pound-Foolish? Highmark Medicare Services’ Proposal for Anticoagulation Clinic Reimbursement
2010
Safety and tolerability of an immediate-release formulation of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation
2010
International consensus statement on the peri‐operative management of anaemia and iron deficiency
2016 Standout
ProTox-II: a webserver for the prediction of toxicity of chemicals
2018 Standout
Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
2009
The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
2011
Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron
2013
How we diagnose and treat iron deficiency anemia
2015
Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective
2007
Medication Use Leading to Emergency Department Visits for Adverse Drug Events in Older Adults
2007
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Opioid Prescriptions for Chronic Pain and Overdose
2010 Standout
Natural product and natural product derived drugs in clinical trials
2014 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Iron-Deficiency Anemia
2015 Standout
ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
2009 Standout
Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia
2014
Guidelines for Perioperative Care in Elective Rectal/Pelvic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations
2012 Standout
Therapeutic Potential of Phosphodiesterase 5 Inhibition for Cardiovascular Disease
2003
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Guideline-concordant administration of prothrombin complex concentrate and vitamin K is associated with decreased mortality in patients with severe bleeding under vitamin K antagonist treatment (EPAHK study)
2014
Works of Lynette Swartz being referenced
Adverse Drug Event Surveillance and Drug Withdrawals in the United States, 1969-2002
2005
Use of parenteral iron products and serious anaphylactic‐type reactions
2010
Comparison of reported and expected deaths in sildenafil (Viagra) users
2002
Bleeding Complications With Warfarin Use
2007
Quality assessment of spontaneous triggered adverse event reports received by the Food and Drug Administration
2012